Literature DB >> 313511

Persistence of inhibitory activity against normal bone-marrow cells during remission of acute leukemia.

H E Broxmeyer, E Grossbard, N Jacobsen, M A Moore.   

Abstract

Bone-marrow cells from patients with acute leukemia in remission were tested for their capacity to produce a substance (leukemia-associated inhibitory activity, LIA) that inhibits the formation of granulocyte and macrophage colonies in cultures of normal, but not of leukemic, bone marrow. LIA was detected in extracts of whole marrow in only eight of 83 patients in remission. However, extracts of slowly sedimenting cells, separated by velocity sedimentation from the marrows of eight patients in remission whose whole marrow had produced no LIA, produced inhibitory material in all cases. Extracts of the more rapidly sedimenting cells from these marrows contained an inactivator of LIA. Three of six patients in remission whose unfractionated marrow was unresponsive to LIA had a subpopulation of colony-forming cells that was sensitive to the inhibitor. These observations suggest that certain cellular functions dot not completely return to normal during remission of acute leukemia.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 313511     DOI: 10.1056/NEJM197908163010702

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  12 in total

Review 1.  Acute non-lymphoblastic leukemias in childhood.

Authors:  M G Dole; R P Warrier; L C Yu
Journal:  Indian J Pediatr       Date:  1989 Nov-Dec       Impact factor: 1.967

2.  Pretreatment of cytokinetics in acute myelogenous leukemia. Age-related prognostic implications.

Authors:  H M Kantarjian; B Barlogie; M J Keating; R R Hall; T L Smith; K B McCredie; E J Freireich
Journal:  J Clin Invest       Date:  1985-07       Impact factor: 14.808

3.  HLA-DR human histocompatibility leukocyte antigens-restricted lymphocyte-monocyte interactions in the release from monocytes of acidic isoferritins that suppress hematopoietic progenitor cells.

Authors:  H E Broxmeyer; L Juliano; L Lu; E Platzer; B Dupont
Journal:  J Clin Invest       Date:  1984-04       Impact factor: 14.808

4.  Identification of leukemia-associated inhibitory activity as acidic isoferritins. A regulatory role for acidic isoferritins in the production of granulocytes and macrophages.

Authors:  H E Broxmeyer; J Bognacki; M H Dorner; M de Sousa
Journal:  J Exp Med       Date:  1981-06-01       Impact factor: 14.307

5.  Treatment of dysmyelopoietic/leukemic syndromes with myelofibrosis and megakaryocytic hyperplasia with large doses of cytosine arabinoside.

Authors:  H D Preisler; A Raza; M Barcos
Journal:  Med Oncol Tumor Pharmacother       Date:  1985

6.  Immunologic diagnosis and monitoring of human acute leukemias: a review.

Authors:  M Maheu; M A Baker; J A Falk; R N Taub
Journal:  Am J Pathol       Date:  1981-04       Impact factor: 4.307

7.  Growth and differentiation patterns of human acute non lymphoid leukemia in diffusion chambers before and after treatment.

Authors:  T Izzi; A Fontebuoni; G Lucarelli
Journal:  Blut       Date:  1981-07

8.  Hypoplastic acute leukemia: description of eight cases and search for hematopoietic inhibiting activity.

Authors:  R de Bock; M de Jonge; M Korthout; E Wouters; D van Bockstaele; M van der Planken; M Peetermans
Journal:  Ann Hematol       Date:  1992-12       Impact factor: 3.673

9.  Relationship of cell-cycle expression of Ia-like antigenic determinants on normal and leukemia human granulocyte-macrophage progenitor cells to regulation in vitro by acidic isoferritins.

Authors:  H E Broxmeyer
Journal:  J Clin Invest       Date:  1982-03       Impact factor: 14.808

10.  Human myeloid leukaemic cell interactions in vitro with normal myeloid colonies.

Authors:  G Spitzer; D S Verma; M Beran; A R Zander; K A Dicke; K B McCredie; S Siegel; S Tindle
Journal:  Br J Cancer       Date:  1981-02       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.